257 related articles for article (PubMed ID: 29338853)
1. Atypical fractures: An issue of concern or a myth?
Al-Ashqar M; Panteli M; Chakrabarty G; Giannoudis PV
Injury; 2018 Mar; 49(3):649-655. PubMed ID: 29338853
[TBL] [Abstract][Full Text] [Related]
2. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
[TBL] [Abstract][Full Text] [Related]
3. Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.
Eisenstein N; Kasavkar G; Bhavsar D; Khan FS; Paskins Z
BMC Musculoskelet Disord; 2017 Jan; 18(1):29. PubMed ID: 28114975
[TBL] [Abstract][Full Text] [Related]
4. Detection and management of atypical femur fractures.
Divan V; Rao SD; Dhaliwal R
Curr Opin Endocrinol Diabetes Obes; 2019 Dec; 26(6):283-290. PubMed ID: 31592780
[TBL] [Abstract][Full Text] [Related]
5. Atypical Femoral Fractures Can Happen Even With Short Duration Bisphosphonate Treatment.
Kohli R; Siva C
Conn Med; 2015 Aug; 79(7):419-22. PubMed ID: 26411180
[TBL] [Abstract][Full Text] [Related]
6. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
7. Atypical diaphyseal femur fractures in patients with prolonged administration of bisphosphonate medication for osteoporosis.
Horning JA; Czajka J; Uhl RL
Orthopedics; 2010 Dec; 33(12):902. PubMed ID: 21117565
[No Abstract] [Full Text] [Related]
8. Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.
Starr J; Tay YKD; Shane E
Curr Osteoporos Rep; 2018 Aug; 16(4):519-529. PubMed ID: 29951870
[TBL] [Abstract][Full Text] [Related]
9. MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.
Adler RA
Eur J Endocrinol; 2018 Mar; 178(3):R81-R87. PubMed ID: 29339529
[TBL] [Abstract][Full Text] [Related]
10. Atypical femur fractures.
Borrelli J; Lane J; Bukata S; Egol KA; Takemoto R; Slobogean G; Morshed S
J Orthop Trauma; 2014; 28 Suppl 1():S36-42. PubMed ID: 24476604
[TBL] [Abstract][Full Text] [Related]
11. Outcomes between older adults with atypical and typical femoral fractures are comparable.
Khow KS; Paterson F; Shibu P; Yu SC; Chehade MJ; Visvanathan R
Injury; 2017 Feb; 48(2):394-398. PubMed ID: 27839798
[TBL] [Abstract][Full Text] [Related]
12. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate therapy and atypical fractures.
Saleh A; Hegde VV; Potty AG; Lane JM
Orthop Clin North Am; 2013 Apr; 44(2):137-51. PubMed ID: 23544820
[TBL] [Abstract][Full Text] [Related]
14. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].
Soen S
Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034
[TBL] [Abstract][Full Text] [Related]
15. Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.
Black DM; Abrahamsen B; Bouxsein ML; Einhorn T; Napoli N
Endocr Rev; 2019 Apr; 40(2):333-368. PubMed ID: 30169557
[TBL] [Abstract][Full Text] [Related]
16. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
17. Medication management after intramedullary nailing of atypical fractures.
Feron JM; Cambon-Binder A
Injury; 2017 Jun; 48 Suppl 1():S15-S17. PubMed ID: 28456365
[TBL] [Abstract][Full Text] [Related]
18. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
[TBL] [Abstract][Full Text] [Related]
19. Trends in the incidence of atypical femoral fractures and bisphosphonate therapy.
Clout A; Narayanasamy N; Harris I
J Orthop Surg (Hong Kong); 2016 Apr; 24(1):36-40. PubMed ID: 27122510
[TBL] [Abstract][Full Text] [Related]
20. A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
Dell R; Greene D
Osteoporos Int; 2018 Jun; 29(6):1277-1283. PubMed ID: 29675745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
